Better Therapeutics, Inc.
BTTX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $26,148 | $109,753 | $75,575 | $235,997 |
| - Cash | $15,740 | $40,566 | $123 | $757 |
| + Debt | $14,880 | $9,505 | $640 | $5,000 |
| Enterprise Value | $25,288 | $78,692 | $76,092 | $240,240 |
| Revenue | $0 | $0 | $8 | $18 |
| % Growth | – | -100% | -55.6% | – |
| Gross Profit | -$2,729 | -$1,619 | -$674 | -$880 |
| % Margin | – | – | -8,425% | -4,888.9% |
| EBITDA | -$38,209 | -$38,684 | -$6,059 | -$5,701 |
| % Margin | – | – | -75,737.5% | -31,672.2% |
| Net Income | -$39,760 | -$40,335 | -$6,387 | -$5,795 |
| % Margin | – | – | -79,837.5% | -32,194.4% |
| EPS Diluted | -1.69 | -1.71 | -1.04 | -0.25 |
| % Growth | 1.2% | -64.4% | -316% | – |
| Operating Cash Flow | -$28,930 | -$30,818 | -$5,774 | -$6,217 |
| Capital Expenditures | -$1,180 | -$1,071 | -$2,305 | -$2,736 |
| Free Cash Flow | -$30,110 | -$31,889 | -$8,079 | -$8,953 |